Graduation day for CancerX’s Accelerator program’s inaugural cohort of startups
CancerX Moonshot shared a post on LinkedIn:
“It’s graduation day for CancerX’s Accelerator program’s inaugural cohort of startups!
For four months, The Blue Box Biomedical Solutions, C the Signs, Cancer Insights, Curiva, EnteroTrack LLC., Gesund.ai, Gray Oncology Solutions, Lind, Mika, Navya Care, Oatmeal Health, Orbit Genomics, Realyze Intelligence, Reimagine Care, SurvivorPlan, XanthosHealth, collaborated with Accelerator Champions, Mentors, federal partners, and CancerX members across the healthcare ecosystem to generate and scale ideas that have the potential to save lives and improve the experience of cancer patients and their caregivers—both strongly tied to CancerX and the Cancer Moonshot goals.
The startups shared ideas for digital innovation in clinical research, screening and diagnosis, treatment and management, clinical operations, and patient, caregiver, and survivor experience, and were selected from a strong pool of over 100 startup applicants.
Judging for the CancerX Accelerator was led by Moffitt Cancer Center and MassChallenge alongside CancerX Accelerator Champions Atrium Health, AstraZeneca, Amazon Web Services (AWS), Debiopharm, Dell Technologies, Intel Corporation, Oncology Ventures, Reveal HealthTech, and UC Davis Health with insight and observation by our federal partners.
By graduating from the Accelerator program, these startups now have a roadmap to successfully scale their company, an opportunity to move forward with their sponsor, and a strong community supporting their development.
And with 16 empowered startups poised for success and equipped with the tools and expertise needed to bring their ideas to life, significant strides are being made in revolutionizing the fight against cancer through digital innovation.
Please join us in recognizing and celebrating these Startups, their Champions, and Mentors, and the incredible impact of their progress in CancerX’s mission to unleash the power of innovation to reduce the burden of cancer for everyone.
We’re thrilled to offer you the chance to be involved in our next cohort! Submissions for Cohort 2025 will open soon, and if you want to join the CancerX Accelerator as a Startup, Champion, or Mentor, be the first to hear about the details for Cohort 2025 by signing up here.”
Source: CancerX Moonshot/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023